POINT OF CARE DIAGNOSTICS

At Leopard Biosciences, we are democratizing diagnostics by bringing the power of molecular testing in the hands of doctors and patients at the point of care. To accomplish this, we are commercializing a proprietary new CRISPR platform that enables multiplex detection of DNA and RNA biomarkers with the ease-of-use of a Lateral Flow Assay and the accuracy and reliability of PCR. With Leopard, we aim to empower patients and healthcare professionals, simplifying patient care and radically changing how healthcare decisions are made.

Founded in 27/06/2023.

www.leopard.bio


Vision of Leopard Biosciences:

"MAxL has been incredibly valuable to Leopard Biosciences‘ startup journey by allowing us to move from idea and concept in the academic lab, to working on product and technology development without delay. With immediate access to well-equipped laboratories, MAxL allows us to continue developing our technology while pursuing external funding, to eventually grow beyond MAxL and get our own laboratories."


The management team of Leopard Biosciences: